Ren X - Search Results

1

Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection.

Yan CH, Lv M, Li H, Song X, Yan F, Cao S, Ren X. Yan CH, et al. Among authors: ren x. J Cancer Res Clin Oncol. 2015 Aug;141(8):1371-8. doi: 10.1007/s00432-014-1902-1. Epub 2015 Jan 3. J Cancer Res Clin Oncol. 2015. PMID: 25555465

2

Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24(+) gastrointestinal cancer patients.

Hao X, Shao Y, Ren X, Liu H, Xu Q, Li H, Zhang P, An X, Ren B. Hao X, et al. Among authors: ren x, ren b. J Cancer Res Clin Oncol. 2002 Sep;128(9):507-15. doi: 10.1007/s00432-002-0358-x. Epub 2002 Aug 21. J Cancer Res Clin Oncol. 2002. PMID: 12242516

3

[Measurement of CD4+CD25+ T cells in breast cancer patients and its significance].

Liu JT, Yue J, Ren XB, Li H. Liu JT, et al. Zhonghua Zhong Liu Za Zhi. 2005 Jul;27(7):423-5. Zhonghua Zhong Liu Za Zhi. 2005. PMID: 16188129 Chinese.

4

[Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].

Li H, Ren XB, Zhang P, An XM, Liu H, Hao XS. Li H, et al. Zhonghua Yi Xue Za Zhi. 2005 Nov 23;85(44):3134-8. Zhonghua Yi Xue Za Zhi. 2005. PMID: 16405818 Chinese.

5

Th1 polarization and apoptosis-inducing activity of CD4+ T -cells in cytokine-induced killers might favor the antitumor cytotoxicity of cytokine-induced killers in vivo.

Yu J, Ren X, Cao S, Zhang W, Hao X. Yu J, et al. Among authors: ren x. Cancer Biother Radiopharm. 2006 Jun;21(3):276-84. doi: 10.1089/cbr.2006.21.276. Cancer Biother Radiopharm. 2006. PMID: 16918305

6

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.

Li H, Yu JP, Cao S, Wei F, Zhang P, An XM, Huang ZT, Ren XB. Li H, et al. J Clin Immunol. 2007 May;27(3):317-26. doi: 10.1007/s10875-007-9076-0. Epub 2007 Apr 28. J Clin Immunol. 2007. PMID: 17468835

7

Antitumor effect of large doses IL-2-activated HLA haploidentical peripheral blood stem cells on refractory metastatic solid tumor treatment.

Ren XB, Yu JP, Cao S, Ren BZ, Li H, Liu H, Min WP, Hao XS. Ren XB, et al. Cancer Biother Radiopharm. 2007 Apr;22(2):223-34. doi: 10.1089/cbr.2007.334. Cancer Biother Radiopharm. 2007. PMID: 17600469 Clinical Trial.

8

[Application of low dose of fludarabine and cyclophosphamide combined with donor NK Cells as a non-myeloablative conditioning regimen for the haploidentical hematopoietic stem cell transplantation in mice].

Yu JP, Cao S, Xin N, An XM, Qi J, Ren XB. Yu JP, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Oct;15(5):1013-8. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17956681 Chinese.

9

[Construction of recombinant adenovirus vector expressing extracellular domain of TbetaR-II-RANTES fusion gene and its anti-tumor effects].

Wang XD, Liu H, Cao S, Li H, Ren XB, Hao XS. Wang XD, et al. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):405-10. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974270 Chinese.

10

Vaccination with allogeneic GM-CSF gene-modified lung cancer cells: antitumor activity comparing with that induced by autologous vaccine.

Li H, Jiang HJ, Ma MQ, Wei F, An XM, Ren XB. Li H, et al. Cancer Biother Radiopharm. 2007 Dec;22(6):790-8. doi: 10.1089/cbr.2007.360. Cancer Biother Radiopharm. 2007. PMID: 18158770

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,233 results

Search Page

Filters